- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 477/20 - Atomes de soufre
Détention brevets de la classe C07D 477/20
Brevets de cette classe: 101
Historique des publications depuis 10 ans
|
3
|
4
|
5
|
2
|
4
|
7
|
0
|
4
|
1
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Shenzhen Haibin Pharmaceutical Co., Ltd. | 16 |
9 |
| CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. | 185 |
7 |
| Ranbaxy Laboratories Limited | 319 |
6 |
| Spero Therapeutics, Inc. | 49 |
6 |
| The Johns Hopkins University | 5642 |
5 |
| Kala Pharmaceuticals, Inc. | 31 |
4 |
| Southern Methodist University | 119 |
4 |
| Asymchem Laboratories (Tianjin) Co., Ltd | 86 |
3 |
| KBP Biosciences Co., Ltd. | 29 |
3 |
| Orchid Chemicals and Pharmaceuticals Limited | 23 |
3 |
| Orchid Chemicals & Pharmaceuticals Limited | 51 |
3 |
| VenatoRx Pharmaceuticals, Inc. | 84 |
3 |
| Xuanzhu Pharma Co., Ltd. | 52 |
3 |
| Jiangsu Desano Pharmaceuticals Co. Ltd. | 4 |
3 |
| Xinxiang Haibin Pharmaceutical Co., Ltd. | 5 |
3 |
| Xuanzhu Biopharmaceutical Co., Ltd. | 35 |
3 |
| Daewoong Pharmaceutical Co., Ltd. | 317 |
2 |
| JW Pharmaceutical Corporation | 76 |
2 |
| Shanghai Cdymax Pharmaceuticals Co., Ltd. | 10 |
2 |
| University of Central Florida Research Foundation, Inc. | 1173 |
2 |
| Autres propriétaires | 25 |